Arcus Biosciences, Inc

(NYSE:RCUS)

Latest On Arcus Biosciences, Inc (RCUS):

Date/Time Type Description Signal Details
2023-05-26 15:40 ESTNewsRoche drives rival anti-TIGIT developers higher after cancer drug dataN/A
2023-05-15 14:11 ESTNewsGilead projects earnings impact after expanding research deal with ArcusN/A
2023-05-10 06:34 ESTNewsArcus Biosciences GAAP EPS of -$1.09 beats by $0.10, revenue of $25M beats by $2.53MN/A
2023-03-23 07:04 ESTNewsArcus Biosciences: Anti-TIGIT Therapy On Track With ARC-7 ResultsN/A
2023-03-01 00:33 ESTNewsArcus Biosciences GAAP EPS of -$0.93 beats by $0.17, revenue of $34M beats by $10.28MN/A
2023-02-02 22:58 ESTNewsRoche CEO drags Arcus, iTeos lower after comments on cancer trialN/A
2022-11-28 16:58 ESTNewsGilead and Arcus issue update from mid-stage trial for lung cancer therapyN/A
2022-11-02 22:20 ESTNewsArcus Biosciences GAAP EPS of -$0.90 beats by $0.17N/A
2022-10-16 14:59 ESTNewsCiti lists four more value-creating events in biotech for this yearN/A
2022-09-10 02:55 ESTNewsArcus Biosciences (RCUS) Investor Presentation - SlideshowN/A
2022-08-11 14:34 ESTNewsArcus Biosciences, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-04 01:07 ESTNewsArcus Biosciences GAAP EPS of -$0.93 beats by $0.01, revenue of $26.8M beats by $5.23MN/A
2022-05-18 12:30 ESTNewsArcus Biosciences, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-14 02:41 ESTNewsArcus medical chief leaves ahead of anti-TIGIT readout - Endpoints NewsN/A
2022-05-11 08:28 ESTNewsRoche drags rivals with anti-TIGIT therapies after setback in lung cancer trialN/A
2022-05-10 12:40 ESTNewsArcus Biosciences GAAP EPS of -$0.96 misses by $0.17, revenue of $18.01M misses by $9.99MN/A
2022-05-08 22:38 ESTNewsArcus Biosciences Q1 2022 Earnings PreviewN/A
2022-04-04 22:19 ESTNewsArcus Biosciences gains 10% on addition to SmallCap 600N/A
2022-02-24 00:58 ESTNewsArcus Biosciences GAAP EPS of $3.71 beats by $4.33, revenue of $354.5M beats by $305.07MN/A
2022-01-25 17:49 ESTNewsArcus Biosciences grants employees options to buy ~39K sharesN/A
2022-01-07 09:25 ESTNewsArcus Biosciences: Not Much Data Yet, But Gilead Deal Is A Huge Value AddN/A
2021-11-30 10:23 ESTNewsArcus Biosciences partner exercises option for anti-TIGIT program covering AsiaN/A
2021-11-18 21:49 ESTNewsArcus Bio gains 15% after Gilead exercises options to three clinical-stage programsN/A
2021-11-18 21:47 ESTNewsSVB Leerink boosts Arcus Biosciences PT on Gilead deal; sees ~171% upsideN/A
2021-11-07 21:21 ESTNewsArcus Biosciences Q3 2021 Earnings PreviewN/A
2021-09-22 04:29 ESTNewsAstraZeneca lung cancer data propel Corvus and ArcusN/A
2021-08-07 23:51 ESTNewsArcus Biosciences, Inc. (RCUS) CEO Terry Rosen on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-06 09:23 ESTNewsArcus Biosciences EPS misses by $0.20, misses on revenueN/A
2021-07-21 21:23 ESTNewsParatek and ResMed price targets raised, Orphazyme downgraded; in today’s analyst actionN/A
2021-07-21 21:19 ESTNewsArcus Biosciences posts positive data from mid-stage domvanalimab lung cancer studyN/A
2021-07-21 20:49 ESTNewsArcus shares drop 5.5% as CMO resigns to take senior oncology position at GileadN/A
2021-05-05 22:03 ESTNewsArcus Biosciences EPS misses by $0.24, misses on revenueN/A
2021-03-11 12:19 ESTAnalyst RatingThe Analyst Target Price has decreased from $53.3 to $53.2.Neutral
2021-03-09 03:29 ESTNewsArcus Biosciences (RCUS) Presents At Cowen 41st Annual Healthcare Virtual Conference - SlideshowN/A
2021-03-02 08:28 ESTAnalyst RatingThe Analyst Target Price has decreased from $53.6 to $53.3.Neutral
2021-03-01 08:28 ESTAnalyst RatingThe Analyst Target Price has increased from $53.2 to $53.6.Buy
2021-02-26 12:16 ESTAnalyst RatingThe Analyst Target Price has increased from $52.5 to $53.2.Buy
2021-02-26 12:16 ESTFinancialsCompany financials have been released.Neutral
2021-02-25 14:26 ESTEarnings EstimateAn EPS average of -$0.82 is estimated for the quarter ending on June 30, 2021.N/A
2021-02-25 14:26 ESTEarnings EstimateAn EPS average of -$3.78 is estimated for the 2022 year.Sell
2021-02-25 08:14 ESTNewsArcus Biosciences EPS misses by $0.11, beats on revenueN/A
2021-02-01 19:03 ESTNewsGilead Sciences raises ownership in Arcus BiosciencesN/A
2021-01-27 08:21 ESTAnalyst RatingThe Analyst Target Price has increased from $51.2 to $52.5.Buy
2021-01-21 12:37 ESTAnalyst RatingThe Analyst Target Price has increased from $48.11 to $51.2.Buy
2021-01-20 08:25 ESTAnalyst RatingThe Analyst Target Price has increased from $47.33 to $48.11.Buy
2021-01-18 04:30 ESTAnalyst RatingThe Analyst Target Price has increased from $42 to $47.33.Buy
2021-01-17 23:27 ESTNewsArcus Biosciences: Highly Valued Even Without A Phase 3 StudyN/A
2021-01-15 14:48 ESTNewsArcus posts positive data from early-stage pancreatic cancer studyN/A
2021-01-14 09:32 ESTAnalyst RatingThe Analyst Target Price has increased from $39.44 to $42.Buy
2021-01-13 04:22 ESTAnalyst RatingThe Analyst Target Price has increased from $38.89 to $39.44.Buy

About Arcus Biosciences, Inc (RCUS):

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for monotherapy. The company is also developing Domvanalimab, an anti-TIGIT monoclonal antibody, which is in Phase 2 development for the treatment of first-line metastatic non-small cell lung cancer in combination with Zimberelimab; and AB680, small-molecule CD73 inhibitor is in a Phase 1/1b study for the treatment of first-line metastatic pancreatic cancer. It has a clinical development collaboration agreement with Strata Oncology, Inc. to evaluate Zimberelimab; a collaboration with AstraZeneca to evaluate domvanalimab, its investigational anti-TIGIT antibody, in combination with Imfinzi (durvalumab) in a registrational Phase 3 clinical trial in patients with unresectable Stage III non-small cell lung cancer; and license agreements with Taiho Pharmaceutical Co., Ltd, Abmuno Therapeutics LLC, and WuXi Biologics to develop anti-CD39 antibody for the treatment of cancer. The company was incorporated in 2015 and is headquartered in Hayward, California.

RCUS Quotes by TradingView

See Advanced Chart

General

  • Name Arcus Biosciences, Inc
  • Symbol RCUS
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 236
  • Fiscal Year EndDecember
  • IPO Date2018-03-15
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.arcusbio.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 26.08
  • Price/Book (Most Recent Quarter) 5.21
  • Enterprise Value Revenue 24.54
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$3.06
  • Next Year EPS Estimate -$3.61
  • Next Quarter EPS Estimate -$0.73
  • Profit Margin -158%
  • Operating Margin -160%
  • Return on Assets -16%
  • Return on Equity -37%
  • Revenue 77.52 million
  • Earnings Per Share -$1.59
  • Revenue Per Share $1.42
  • Gross Profit -81831000
  • Quarterly Earnings Growth -2.7%
View More

Highlights

  • Market Capitalization 2.5 billion
  • EBITDA -69803000
  • PE Ratio -4.59
  • Analyst Target Price $53.2
  • Book Value Per Share $7.71
View More

Share Statistics

  • Shares Outstanding 64.92 million
  • Shares Float 44.97 million
  • % Held by Insiders 3199%
  • % Held by Institutions 65.3%
  • Shares Short 5.89 million
  • Shares Short Prior Month 5.99 million
  • Short Ratio 11.65
  • Short % of Float 10%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 1.16
  • 52 Week High $42.36
  • 52 Week Low $9.86
  • 50 Day Moving Average 35.76
  • 200 Day Moving Average 27.72
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Arcus Biosciences, Inc (RCUS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Arcus Biosciences, Inc (RCUS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$9.49 million-$0.82-$0.79-3.68%
2020-09-302020-11-05$64.53 million$0.03-$0.76103.93%
2020-06-302020-08-06$N/A-$0.93-$0.58-59.19%
2020-03-312020-05-05$1.75 million-$0.63-$0.56-12.72%
2019-12-312020-03-05$9.75 million-$0.38-$0.5023.74%
2019-09-302019-11-05$1.75 million-$0.51-$0.521.6%
2019-06-302019-08-06$1.75 million-$0.64-$0.41-54.85%
2019-03-312019-05-02$1.75 million-$0.41-$0.34-19.71%
2018-12-312019-03-05$1.56 million-$0.28-$0.4537.14%
2018-09-302018-11-08$4.29 million-$0.25-$0.3529.32%
2018-06-302018-08-06$1.25 million-$0.32-$0.4019.23%
2018-03-312018-05-09$1.25 million-$0.37-$0.4313.95%

Arcus Biosciences, Inc (RCUS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development 48.71 million 51.8 million N/A 23.14 million 20.69 million
Income Before Tax -51.85 million 1.82 million N/A -27.75 million -16.6 million
Selling General Administrative 12.79 million 11.18 million N/A 7.01 million 6.59 million
Gross Profit 9.49 million N/A N/A N/A N/A
Ebit -51.85 million 2.29 million N/A -27.56 million -16.67 million
Operating Income -52.01 million 1.55 million N/A -28.4 million -17.53 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue 9.49 million 64.53 million N/A 1.75 million 9.75 million
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A N/A N/A
Net Income From Continuing Operations -51.85 million 1.82 million N/A -27.75 million -16.6 million
Net Income Applicable to Common Shares -51.85 million 1.82 million -45.07 million N/A N/A
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments -387.12 million N/A 40.06 million -12.1 million 30.91 million
Change to Liabilities 187.89 million 7.26 million N/A N/A 3.72 million
Total Cash Flow from Investing Activities -387.12 million -87.07 million N/A N/A 30.36 million
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities 107.52 million N/A 610000 520000 -41000
Change to Operating Activities 22.18 million 8.57 million N/A N/A -6.84 million
Change in Cash -63.34 million N/A 9.39 million -21.06 million 2.92 million
Total Cash from Operating Activities 216.27 million -23.94 million -31.28 million N/A -27.4 million
Depreciation 742000 N/A 842000 856000 886000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables -2.36 million N/A -212000 5.14 million -5.28 million
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 5.99 million 4.4 million N/A N/A 2.47 million
Capital Expenditures 1.07 million N/A 209000 196000 550000
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 269.99 million N/A N/A 35.51 million 39.27 million
Total Stockholder Equity 502.3 million N/A N/A 140.64 million 163.84 million
Other Current Liabilities 78.14 million 119.04 million N/A 1.41 million 1.48 million
Total Assets 772.29 million N/A N/A 176.14 million 203.11 million
Common Stock 6000 6000 6000 N/A N/A
Other Current Assets 6.52 million N/A N/A N/A N/A
Retained Earnings -328.18 million -276.33 million -278.15 million -233.08 million -205.33 million
Other Liabilities N/A 103.79 million 12.65 million N/A N/A
Other Assets N/A 2.45 million 1.53 million N/A N/A
Cash 173.42 million N/A N/A 67.33 million 57.94 million
Total Current Liabilities 121.67 million 162.87 million N/A 21 million 22.71 million
Other Stockholder Equity 44000 81000 144000 N/A N/A
Property, Plant & Equipment 10.81 million 8.73 million 8.26 million N/A N/A
Total Current Assets 735.82 million 797.2 million N/A 166.22 million 192.71 million
Long Term Investments 6.44 million N/A N/A N/A N/A
Net Tangible Assets 502.3 million 544.42 million 428.71 million N/A N/A
Short Term Investments 555.23 million N/A N/A 90.54 million 130.33 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 43.53 million 8.1 million N/A 2.43 million 4.7 million

Arcus Biosciences, Inc (RCUS) Chart:

Arcus Biosciences, Inc (RCUS) News:

Below you will find a list of latest news for Arcus Biosciences, Inc (RCUS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Arcus Biosciences, Inc (RCUS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50CALL0 0533.06TRUE00
2024-05-1750CALL0 0410.55TRUE00
2024-05-177.50CALL0 0276.27TRUE00
2024-05-17100CALL0 0192.91TRUE00
2024-05-1712.52.85CALL0 374978.08TRUE00
2024-05-17151.6CALL0 870TRUE00
2024-05-1717.50.4CALL0 17368.42FALSE00
2024-05-17200.19CALL0 270FALSE00
2024-05-1722.50.6CALL0 110FALSE00
2024-05-17250CALL0 00FALSE00
2024-05-17300CALL0 00FALSE00
2024-05-17350CALL0 00FALSE00
2024-05-172.50PUT0 00FALSE00
2024-05-1750PUT0 00FALSE00
2024-05-177.50PUT0 00FALSE00
2024-05-17100PUT0 00FALSE00
2024-05-1712.50.3PUT0 40FALSE00
2024-05-17150.71PUT0 35868.23FALSE00
2024-05-1717.51.75PUT0 21146.48TRUE00
2024-05-17200PUT0 0258.6TRUE00
2024-05-1722.50PUT0 0238.03TRUE00
2024-05-17250PUT0 0136.56TRUE00
2024-05-17300PUT0 0177.06TRUE00
2024-05-17350PUT0 0228.41TRUE00
2024-06-212.50CALL0 0305.43TRUE00
2024-06-2150CALL0 0214.19TRUE00
2024-06-217.50CALL0 0184.53TRUE00
2024-06-21100CALL0 0109.16TRUE00
2024-06-2112.50CALL0 091.98TRUE00
2024-06-21150CALL0 067.74TRUE00
2024-06-2117.51.05CALL0 289.21FALSE00
2024-06-21200.45CALL1 4673.17FALSE-0.1-0.18
2024-06-2122.50.2CALL0 70FALSE00
2024-06-21250CALL0 00FALSE00
2024-06-21300CALL0 00FALSE00
2024-06-212.50PUT0 00FALSE00
2024-06-2150PUT0 00FALSE00
2024-06-217.50PUT0 00FALSE00
2024-06-21100PUT0 00FALSE00
2024-06-2112.50PUT0 095.9FALSE00
2024-06-21151.22PUT0 756.37FALSE00
2024-06-2117.50PUT0 0113.16TRUE00
2024-06-21200PUT0 085.38TRUE00
2024-06-2122.50PUT0 0133.58TRUE00
2024-06-21250PUT0 088.21TRUE00
2024-06-21300PUT0 0113.06TRUE00
2024-07-192.50CALL0 0275.15TRUE00
2024-07-19513.25CALL0 0167.33TRUE00
2024-07-197.50CALL0 0134.43TRUE00
2024-07-19109.25CALL0 1100.04TRUE00
2024-07-1912.56.55CALL0 12990.91TRUE00
2024-07-19152.3CALL0 397107.33TRUE00
2024-07-1917.51.2CALL0 53679.27FALSE00
2024-07-19200.8CALL0 70770.04FALSE00
2024-07-1922.50.4CALL0 101110.64FALSE00
2024-07-19250.32CALL0 32110.75FALSE00
2024-07-19300.71CALL0 3490FALSE00
2024-07-19350.35CALL0 5040FALSE00
2024-07-192.50PUT0 00FALSE00
2024-07-1950PUT0 00FALSE00
2024-07-197.50PUT0 00FALSE00
2024-07-19100.3PUT0 10567.44FALSE00
2024-07-1912.50.75PUT0 4871.02FALSE00
2024-07-19151.85PUT0 39676.22FALSE00
2024-07-1917.52.65PUT0 36481.93TRUE00
2024-07-19204.41PUT0 890.3TRUE00
2024-07-1922.57.79PUT0 377.45TRUE00
2024-07-19250PUT0 0106.58TRUE00
2024-07-19300PUT0 0186.73TRUE00
2024-07-19350PUT0 0211.11TRUE00
2024-10-182.50CALL0 0180.46TRUE00
2024-10-1850CALL0 0141.19TRUE00
2024-10-187.50CALL0 088.59TRUE00
2024-10-18100CALL0 090.35TRUE00
2024-10-1812.54.28CALL0 984.82TRUE00
2024-10-18153.4CALL1 3372.96TRUE3.40
2024-10-1817.52.33CALL0 39692.55FALSE00
2024-10-18201.47CALL0 3165.65FALSE00
2024-10-1822.50CALL0 083.84FALSE00
2024-10-18251.11CALL0 469.24FALSE00
2024-10-18302CALL0 196.12FALSE00
2024-10-18351.25CALL0 20FALSE00
2024-10-182.50PUT0 00FALSE00
2024-10-1850PUT0 00FALSE00
2024-10-187.50PUT0 00FALSE00
2024-10-18100.55PUT0 12665.9FALSE00
2024-10-1812.51.5PUT0 2178.46FALSE00
2024-10-18152.4PUT0 2360.65FALSE00
2024-10-1817.54.47PUT0 30452.29TRUE00
2024-10-18205PUT0 674.88TRUE00
2024-10-1822.50PUT0 071.14TRUE00
2024-10-18250PUT0 095.72TRUE00
2024-10-18300PUT0 097.84TRUE00
2024-10-18350PUT0 080.62TRUE00

Latest RCUS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST59$19.77
Jun 13, 2022 7:59 PM EST1$19.775
Jun 13, 2022 7:59 PM EST100$19.775
Jun 13, 2022 7:59 PM EST8$19.77
Jun 13, 2022 7:59 PM EST100$19.775

Arcus Biosciences, Inc (RCUS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724521/000083423720009542/0000834237-20-009542-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724521/000083423720007981/0000834237-20-007981-index.htm
2020-06-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724521/000083423720009542/0000834237-20-009542-index.htm
2018-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000089924318007985/0000899243-18-007985-index.htm
2018-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000089924318007986/0000899243-18-007986-index.htm
2018-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000089924318007987/0000899243-18-007987-index.htm
2018-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000089924318007988/0000899243-18-007988-index.htm
2018-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000089924318007990/0000899243-18-007990-index.htm
2018-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000089924318008009/0000899243-18-008009-index.htm
2018-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000089924318016209/0000899243-18-016209-index.htm
2018-10-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000089924318027178/0000899243-18-027178-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000089924318027179/0000899243-18-027179-index.htm
2019-01-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000089924319001253/0000899243-19-001253-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724521/000090221919000128/0000902219-19-000128-index.htm
2020-01-27SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724521/000090221920000128/0000902219-20-000128-index.htm
2018-11-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724521/000092189518003149/0000921895-18-003149-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724521/000092189519000454/0000921895-19-000454-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724521/000092189520000532/0000921895-20-000532-index.htm
2020-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000110465920084443/0001104659-20-084443-index.htm
2020-07-17SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724521/000110465920084444/0001104659-20-084444-index.htm
2018-03-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724521/000114420418016667/0001144204-18-016667-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724521/000114420419007020/0001144204-19-007020-index.htm
2018-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000119312518157570/0001193125-18-157570-index.htm
2018-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000119312518189988/0001193125-18-189988-index.htm
2018-07-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000119312518216938/0001193125-18-216938-index.htm
2018-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000119312518303658/0001193125-18-303658-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000119312519001973/0001193125-19-001973-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724521/000119312519034465/0001193125-19-034465-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724521/000119312519038141/0001193125-19-038141-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000119312519085285/0001193125-19-085285-index.htm
2019-04-02S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1724521/000119312519094771/0001193125-19-094771-index.htm
2019-04-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1724521/000119312519115020/0001193125-19-115020-index.htm
2019-04-26424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1724521/000119312519122574/0001193125-19-122574-index.htm
2019-05-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1724521/000119312519158321/0001193125-19-158321-index.htm
2019-11-258-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000119312519299841/0001193125-19-299841-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724521/000119312520035315/0001193125-20-035315-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000119312520152272/0001193125-20-152272-index.htm
2020-05-27S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1724521/000119312520153138/0001193125-20-153138-index.htm
2020-05-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1724521/000119312520153449/0001193125-20-153449-index.htm
2020-05-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1724521/000119312520155954/0001193125-20-155954-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000119312520155962/0001193125-20-155962-index.htm
2020-11-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724521/000119312520285646/0001193125-20-285646-index.htm
2018-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919118046475/0001209191-18-046475-index.htm
2018-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919118046476/0001209191-18-046476-index.htm
2018-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919118047133/0001209191-18-047133-index.htm
2018-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919118047851/0001209191-18-047851-index.htm
2018-08-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919118048417/0001209191-18-048417-index.htm
2018-08-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919118048775/0001209191-18-048775-index.htm
2018-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919118058692/0001209191-18-058692-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119004477/0001209191-19-004477-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119004478/0001209191-19-004478-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119004497/0001209191-19-004497-index.htm
2019-03-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119021205/0001209191-19-021205-index.htm
2019-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119021233/0001209191-19-021233-index.htm
2019-05-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119026750/0001209191-19-026750-index.htm
2019-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119026755/0001209191-19-026755-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119034201/0001209191-19-034201-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119034622/0001209191-19-034622-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119035453/0001209191-19-035453-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119035740/0001209191-19-035740-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119035743/0001209191-19-035743-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119035745/0001209191-19-035745-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119035749/0001209191-19-035749-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119035752/0001209191-19-035752-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119036275/0001209191-19-036275-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119036960/0001209191-19-036960-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119037024/0001209191-19-037024-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119039547/0001209191-19-039547-index.htm
2019-10-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119052533/0001209191-19-052533-index.htm
2019-10-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119053207/0001209191-19-053207-index.htm
2019-10-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119054494/0001209191-19-054494-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119054500/0001209191-19-054500-index.htm
2019-12-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119060166/0001209191-19-060166-index.htm
2019-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919119060168/0001209191-19-060168-index.htm
2020-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120004396/0001209191-20-004396-index.htm
2020-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120004398/0001209191-20-004398-index.htm
2020-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120004401/0001209191-20-004401-index.htm
2020-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120004403/0001209191-20-004403-index.htm
2020-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120004405/0001209191-20-004405-index.htm
2020-05-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120031999/0001209191-20-031999-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120032004/0001209191-20-032004-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120034974/0001209191-20-034974-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120034977/0001209191-20-034977-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120034978/0001209191-20-034978-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120034981/0001209191-20-034981-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120034984/0001209191-20-034984-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120034985/0001209191-20-034985-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120034986/0001209191-20-034986-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120034991/0001209191-20-034991-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120034995/0001209191-20-034995-index.htm
2020-07-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120042304/0001209191-20-042304-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120044798/0001209191-20-044798-index.htm
2020-08-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120044800/0001209191-20-044800-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120044848/0001209191-20-044848-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120046182/0001209191-20-046182-index.htm
2020-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120049846/0001209191-20-049846-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120053707/0001209191-20-053707-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120053710/0001209191-20-053710-index.htm
2020-10-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724521/000120919120054918/0001209191-20-054918-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724521/000156459018012447/0001564590-18-012447-index.htm
2018-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459018019442/0001564590-18-019442-index.htm
2018-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724521/000156459018019459/0001564590-18-019459-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459018028577/0001564590-18-028577-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724521/000156459018028583/0001564590-18-028583-index.htm
2019-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459019006268/0001564590-19-006268-index.htm
2019-03-0510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1724521/000156459019006274/0001564590-19-006274-index.htm
2019-03-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1724521/000156459019006280/0001564590-19-006280-index.htm
2019-03-298-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459019009885/0001564590-19-009885-index.htm
2019-04-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1724521/000156459019012273/0001564590-19-012273-index.htm
2019-04-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1724521/000156459019012285/0001564590-19-012285-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459019015044/0001564590-19-015044-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724521/000156459019015333/0001564590-19-015333-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459019021952/0001564590-19-021952-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459019029369/0001564590-19-029369-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724521/000156459019029385/0001564590-19-029385-index.htm
2019-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459019033888/0001564590-19-033888-index.htm
2019-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459019034806/0001564590-19-034806-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459019038142/0001564590-19-038142-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459019040412/0001564590-19-040412-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724521/000156459019040421/0001564590-19-040421-index.htm
2019-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459019045786/0001564590-19-045786-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459020008968/0001564590-20-008968-index.htm
2020-03-0510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1724521/000156459020008972/0001564590-20-008972-index.htm
2020-03-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1724521/000156459020008991/0001564590-20-008991-index.htm
2020-03-05SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724521/000156459020008994/0001564590-20-008994-index.htm
2020-03-05SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724521/000156459020008996/0001564590-20-008996-index.htm
2020-04-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459020015612/0001564590-20-015612-index.htm
2020-04-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1724521/000156459020017693/0001564590-20-017693-index.htm
2020-04-21DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1724521/000156459020017696/0001564590-20-017696-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459020021265/0001564590-20-021265-index.htm
2020-05-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724521/000156459020021282/0001564590-20-021282-index.htm
2020-05-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459020026867/0001564590-20-026867-index.htm
2020-05-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1724521/000156459020026870/0001564590-20-026870-index.htm
2020-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459020028493/0001564590-20-028493-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459020031945/0001564590-20-031945-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459020032260/0001564590-20-032260-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459020037759/0001564590-20-037759-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724521/000156459020037782/0001564590-20-037782-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459020045553/0001564590-20-045553-index.htm
2020-10-15SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724521/000156459020046531/0001564590-20-046531-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724521/000156459020051327/0001564590-20-051327-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724521/000156459020051355/0001564590-20-051355-index.htm
2019-04-25EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1724521/999999999519000834/9999999995-19-000834-index.htm
2018-11-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1724521/999999999718009009/9999999997-18-009009-index.htm

Arcus Biosciences, Inc (RCUS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arcus Biosciences, Inc (RCUS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 3199%
Institutional Ownership: 6530%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-10-10William GrossmanChief Medical OfficerBuy100.008.00800.00100.00https://www.sec.gov/Archives/edgar/data/1724521/000120919119053207/0001209191-19-053207-index.htm
2020-06-04Jason BarkerOfficerBuy10,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120034974/0001209191-20-034974-index.htm
2020-10-02William GrossmanChief Medical OfficerBuy100,000.00100,600.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120053710/0001209191-20-053710-index.htm
2020-06-04Jennifer JarrettDirectorBuy3,000.00103,634.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120034984/0001209191-20-034984-index.htm
2020-06-04Juan C. JaenPresidentBuy55,000.00244,393.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120034981/0001209191-20-034981-index.htm
2018-03-19Juan C. JaenPresidentBuy66,666.0015.00999,990.002,734,240.00https://www.sec.gov/Archives/edgar/data/1724521/000089924318007987/0000899243-18-007987-index.htm
2018-08-09Juan C. JaenPresidentBuy4,262.0011.9350,855.462,738,502.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118046476/0001209191-18-046476-index.htm
2018-08-10Juan C. JaenPresidentBuy2,579.0011.9430,796.352,741,081.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118046476/0001209191-18-046476-index.htm
2018-08-13Juan C. JaenPresidentBuy3,159.0011.7737,168.162,744,240.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118046476/0001209191-18-046476-index.htm
2018-11-13Juan C. JaenPresidentBuy10,000.0011.80118,039.002,754,240.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118058692/0001209191-18-058692-index.htm
2019-06-03Juan C. JaenPresidentBuy10,000.008.2582,485.002,764,240.00https://www.sec.gov/Archives/edgar/data/1724521/000120919119034201/0001209191-19-034201-index.htm
2019-06-27Juan C. JaenPresidentBuy10,106.007.4475,216.942,774,346.00https://www.sec.gov/Archives/edgar/data/1724521/000120919119039547/0001209191-19-039547-index.htm
2019-06-28Juan C. JaenPresidentBuy4,894.007.8938,636.662,779,240.00https://www.sec.gov/Archives/edgar/data/1724521/000120919119039547/0001209191-19-039547-index.htm
2020-06-04TERRY J ROSENChief Executive OfficerBuy100,000.00289,393.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120034995/0001209191-20-034995-index.htm
2019-06-03TERRY J ROSENChief Executive OfficerBuy15,770.008.16128,749.432,975,631.00https://www.sec.gov/Archives/edgar/data/1724521/000120919119034622/0001209191-19-034622-index.htm
2020-06-04Patrick MachadoDirectorBuy3,000.003,000.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120034986/0001209191-20-034986-index.htm
2020-06-04YASUNORI KANEKODirectorBuy3,000.003,000.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120034985/0001209191-20-034985-index.htm
2019-06-04TERRY J ROSENChief Executive OfficerBuy25,770.007.75199,825.733,001,401.00https://www.sec.gov/Archives/edgar/data/1724521/000120919119034622/0001209191-19-034622-index.htm
2019-06-05TERRY J ROSENChief Executive OfficerBuy19,358.007.93153,416.023,020,759.00https://www.sec.gov/Archives/edgar/data/1724521/000120919119035453/0001209191-19-035453-index.htm
2019-06-06TERRY J ROSENChief Executive OfficerBuy2,380.007.9518,928.143,023,139.00https://www.sec.gov/Archives/edgar/data/1724521/000120919119035453/0001209191-19-035453-index.htm
2020-08-07TERRY J ROSENChief Executive OfficerBuy11,655.0021.44249,911.173,199,129.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120046182/0001209191-20-046182-index.htm
2020-08-10TERRY J ROSENChief Executive OfficerBuy32,050.0023.38749,402.723,231,179.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120046182/0001209191-20-046182-index.htm
2020-06-05YASUNORI KANEKODirectorBuy35,000.007.99279,650.0038,000.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120034985/0001209191-20-034985-index.htm
2018-03-19TERRY J ROSENChief Executive OfficerBuy66,666.0015.00999,990.003,884,744.00https://www.sec.gov/Archives/edgar/data/1724521/000089924318007985/0000899243-18-007985-index.htm
2018-08-09TERRY J ROSENChief Executive OfficerBuy4,100.0011.9248,869.133,888,844.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118046475/0001209191-18-046475-index.htm
2018-08-10TERRY J ROSENChief Executive OfficerBuy2,550.0011.9430,450.573,891,394.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118046475/0001209191-18-046475-index.htm
2018-08-13TERRY J ROSENChief Executive OfficerBuy3,279.0011.7538,534.153,894,673.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118046475/0001209191-18-046475-index.htm
2018-08-14TERRY J ROSENChief Executive OfficerBuy6,169.0012.3676,238.973,900,842.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118047133/0001209191-18-047133-index.htm
2018-08-15TERRY J ROSENChief Executive OfficerBuy13,300.0012.57167,239.523,914,142.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118047133/0001209191-18-047133-index.htm
2019-06-07KATHRYN E FALBERGDirectorBuy22,065.007.99176,297.1439,171.00https://www.sec.gov/Archives/edgar/data/1724521/000120919119036275/0001209191-19-036275-index.htm
2018-08-16TERRY J ROSENChief Executive OfficerBuy8,932.0012.95115,648.863,923,074.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118047133/0001209191-18-047133-index.htm
2018-08-17TERRY J ROSENChief Executive OfficerBuy4,800.0013.2763,712.803,927,874.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118047851/0001209191-18-047851-index.htm
2018-08-20TERRY J ROSENChief Executive OfficerBuy1,301.0013.2117,186.213,929,175.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118047851/0001209191-18-047851-index.htm
2018-08-21TERRY J ROSENChief Executive OfficerBuy2,790.0013.2036,828.003,931,965.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118047851/0001209191-18-047851-index.htm
2018-08-22TERRY J ROSENChief Executive OfficerBuy2,202.0013.5229,776.553,934,167.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118048417/0001209191-18-048417-index.htm
2018-08-23TERRY J ROSENChief Executive OfficerBuy2,133.0013.5028,800.193,936,300.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118048417/0001209191-18-048417-index.htm
2018-08-24TERRY J ROSENChief Executive OfficerBuy4,954.0013.4066,363.293,941,254.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118048417/0001209191-18-048417-index.htm
2018-08-27TERRY J ROSENChief Executive OfficerBuy7,157.0014.48103,649.113,948,411.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118048775/0001209191-18-048775-index.htm
2018-08-27TERRY J ROSENChief Executive OfficerBuy800.0014.9211,937.043,949,211.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118048775/0001209191-18-048775-index.htm
2018-08-28TERRY J ROSENChief Executive OfficerBuy10,650.0015.48164,844.963,959,861.00https://www.sec.gov/Archives/edgar/data/1724521/000120919118048775/0001209191-18-048775-index.htm
2019-10-14William GrossmanChief Medical OfficerBuy300.008.002,400.00400.00https://www.sec.gov/Archives/edgar/data/1724521/000120919119053207/0001209191-19-053207-index.htm
2019-06-10KATHRYN E FALBERGDirectorBuy10,000.008.2582,500.0049,171.00https://www.sec.gov/Archives/edgar/data/1724521/000120919119036275/0001209191-19-036275-index.htm
2020-07-31William GrossmanChief Medical OfficerBuy100.0019.771,977.00500.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120044798/0001209191-20-044798-index.htm
2020-09-09II Robert C. GoeltzChief Financial OfficerBuy5,000.0021.57107,848.505,000.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120049846/0001209191-20-049846-index.htm
2020-06-04William GrossmanChief Medical OfficerBuy55,000.0055,400.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120034978/0001209191-20-034978-index.htm
2019-06-11KATHRYN E FALBERGDirectorBuy10,000.007.9079,000.0059,171.00https://www.sec.gov/Archives/edgar/data/1724521/000120919119036960/0001209191-19-036960-index.htm
2020-07-31William GrossmanChief Medical OfficerBuy100.0019.681,967.56600.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120044798/0001209191-20-044798-index.htm
2019-06-12KATHRYN E FALBERGDirectorBuy10,000.008.4984,928.0069,171.00https://www.sec.gov/Archives/edgar/data/1724521/000120919119036960/0001209191-19-036960-index.htm
2020-06-04Antoni RibasDirectorBuy3,000.008,050.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120034991/0001209191-20-034991-index.htm
2019-06-13KATHRYN E FALBERGDirectorBuy12,935.008.52110,151.8782,106.00https://www.sec.gov/Archives/edgar/data/1724521/000120919119037024/0001209191-19-037024-index.htm
2020-06-04KATHRYN E FALBERGDirectorBuy3,000.0083,504.00https://www.sec.gov/Archives/edgar/data/1724521/000120919120034977/0001209191-20-034977-index.htm